不同胎龄及出生体重早产儿血游离肉碱变化特点

齐志业; 段江; 王琼; 姚勤; 钟庆华; 张彩营; 梁琨

doi:10.7499/j.issn.1008-8830.2019.06.012

PDF(1339 KB)

HTML

中国当代儿科杂志 ›› 2019, Vol. 21 ›› Issue (6) : 562-566. DOI: 10.7499/j.issn.1008-8830.2019.06.012

论著·临床研究

不同胎龄及出生体重早产儿血游离肉碱变化特点

齐志业¹, 段江¹, 王琼¹, 姚勤², 钟庆华¹, 张彩营¹, 梁琨¹

作者信息 +

Levels of blood free carnitine in preterm infants with different gestational ages and birth weights

QI Zhi-Ye¹, DUAN Jiang¹, WANG Qiong¹, YAO Qin², ZHONG Qing-Hua¹, ZHANG Cai-Ying¹, LIANG Kun¹

Author information +

文章历史 +

摘要

目的检测不同胎龄及出生体重早产儿血游离肉碱（FC）浓度，为制定早产儿FC补充治疗方案提供依据。方法选取3 368例早产儿为研究对象。根据胎龄（GA）分为超早产（EPTB，GA<28周）组（n=39）、极早产（VPTB，28≤GA < 32周）组（n=405）、中期早产（MPTB，32≤GA<34周）组（n=507）、晚期早产（LPTB，34≤GA<37周）组（n=2 417）；根据出生体重（BW）分为超低出生体重（ELBW，BW < 1 000 g）组（n=36）、极低出生体重（VLBW，1 000 g≤BW < 1 500 g）组（n=387）、低出生体重组（LBW，1 500 g≤BW < 2 500 g）组（n=1 873）、正常出生体重（NBW，2 500 g≤BW≤4 000 g）组（n=1 072）。于生后72 h~7 d内采血进行FC浓度测定并进行比较。结果 EPTB、VPTB组FC浓度明显高于MPTB、LPTB组（P < 0.05），MPTB组FC浓度明显高于LPTB组（P < 0.05）；胎龄越小，FC的95%医学参考范围下限越高。ELBW、VLBW组FC浓度明显高于LBW、NBW组（P < 0.05），LBW组FC浓度明显高于NBW组（P < 0.05）；出生体重越低，FC的95%医学参考范围下限越高。结论极/超早产儿、极/超低出生体重儿血FC浓度明显升高，并且随着胎龄及出生体重的增加呈明显下降的趋势。

Abstract

Objective To examine blood concentrations of free carnitine (FC) in preterm infants with different gestational ages (GA) and birth weights (BW). Methods A total of 3 368 preterm infants were enrolled as subjects. According to GA, they were divided into extremely preterm birth (EPTB) group (GA <28 weeks; n=39), very preterm birth (VPTB) group (28 ≤ GA <32 weeks; n=405), moderately preterm birth (MPTB) group (32 ≤ GA < 34 weeks; n=507), and late preterm birth (LPTB) group (34 ≤ GA <37 weeks; n=2 417); according to BW, they were divided into extremely low birth weight (ELBW) group (BW <1 000 g; n=36), very low birth weight (VLBW) group (1 000 g ≤ BW < 1 500 g; n=387), low birth weight (LBW) group (1 500 g ≤ BW < 2 500 g; n=1 873), and normal birth weight (NBW) group (2 500 g ≤ BW <4 000 g; n=1 072). Blood concentrations of FC were measured between 72 hours and 7 days after birth. Results The EPTB and VPTB groups had significantly higher FC concentrations than the MPTB and LPTB groups (P < 0.05), and the MPTB group had significantly higher FC concentrations than the LPTB group (P < 0.05). The lower limit of the 95% medical reference range of FC increased with the reduction in GA. The ELBW and VLBW groups had significantly higher FC concentrations than the LBW and NBW groups (P < 0.05). The LBW group had significantly higher FC concentrations than the NBW group (P < 0.05). The lower limit of the 95% medical reference range of FC increased with the reduction in BW. Conclusions There is a significant increase in blood FC concentrations in very/extremely preterm infants and very/extremely low birth weight infants, and tend to decrease with the increases in GA and BW.

导出引用

齐志业, 段江, 王琼, 姚勤, 钟庆华, 张彩营, 梁琨. 不同胎龄及出生体重早产儿血游离肉碱变化特点[J]. 中国当代儿科杂志. 2019, 21(6): 562-566 https://doi.org/10.7499/j.issn.1008-8830.2019.06.012

QI Zhi-Ye, DUAN Jiang, WANG Qiong, YAO Qin, ZHONG Qing-Hua, ZHANG Cai-Ying, LIANG Kun. Levels of blood free carnitine in preterm infants with different gestational ages and birth weights[J]. Chinese Journal of Contemporary Pediatrics. 2019, 21(6): 562-566 https://doi.org/10.7499/j.issn.1008-8830.2019.06.012

参考文献

[1] Slicker J, Vermilyea S. Pediatric parenteral nutrition:putting the microscope on macronutrients and micronutrients[J]. Nutr Clin Pract, 2009, 24(4):481-486.
[2] 王德胜, 冯丽燕, 陈燕梅, 等. 左卡尼汀补充对早产儿血浆游离肉碱影响及其意义[J]. 实用医学杂志, 2016, 32(20):3429-3431.
[3] Seliger G, Kantelhardt EJ, Van Der Wal C, et al. L-carnitine level in neonates - a large, retrospective analysis[J]. Arch Perinatal Med, 2007, 13:17-20.
[4] Meyburg J, Schulze A, Kohlmueller D, et al. Acylcarnitine profiles of preterm infants over the first four weeks of life[J]. Pediatr Res, 2002, 52(5):720-723.
[5] 于福文. 左卡尼汀在营养治疗中的研究进展[J]. 天津药学, 2016, 28(4):51-55.
[6] 曹云. 营养与早产儿神经发育结局[J]. 临床儿科杂志, 2012, 30(3):208-211.
[7] 唐慧, 杨传忠, 李欢, 等. 不同胎龄早产儿生后早期对脂肪乳的耐受性研究[J]. 中国当代儿科杂志, 2017, 19(6):632-637.
[8] 刘嫣然, 包蕾. 左卡尼汀在新生儿的临床应用[J]. 儿科药学杂志, 2016, 22(7):60-63.
[9] Clark RH, Chace DH, Spitzer AR. Impact of L-carnitine supplementation on metabolic profiles in premature infants[J]. J Perinatol, 2017, 37(5):566-571.
[10] Crill CM, Helms RA. The use of carnitine in pediatric nutrition[J]. Nutr Clin Pract, 2007, 22(2):204-213.
[11] Ozturk MA, Kardas Z, Kardas F, et al. Effects of L-carnitine supplementation on respiratory distress syndrome development and prognosis in premature infants:a single blind randomized controlled trial[J]. Exp Ther Med, 2016, 11(3):1123-1127.
[12] Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children[J]. Pharmacotherapy, 2002, 22(2):188-211.
[13] Bonner CM, DeBrie KL, Hug G, et al. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates[J]. J Pediatr, 1995, 126(2):287-292.
[14] 林多华, 肖厚兰, 刘新华, 等. 左卡尼汀在早产儿静脉营养的应用研究[J]. 重庆医学, 2015, 44(2):192-193, 196.
[15] 谭小华, 崔其亮, 李颖, 等. 不同方法补充左卡尼汀对新生儿血浆肉碱水平的影响及临床意义[J]. 儿科药学杂志, 2012, 18(4):4-7.
[16] Whitfield J, Smith T, Sollohub H, et al. Clinical effects of L-carnitine supplementation on apnea and growth in very low birth weight infants[J]. Pediatrics, 2003, 111(3):477-482.
[17] Seong SH, Cho SC, Park Y, et al. L-carnitine-supplemented parenteral nutrition improves fat metabolism but fails to support compensatory growth in premature Korean infants[J]. Nutr Res, 2010, 30(4):233-239.